首页 | 本学科首页   官方微博 | 高级检索  
     


Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non-Hodgkin lymphoma
Authors:Gerecitano John  Gounder Sivaraman  Teruya-Feldstein Julie  Arcila Maria  Ogilvie Shahiba  Gonzalez Camille  Lin Dorothy  Zheng Junting  Zhang Zhigang  McDonald Alice  Mulligan George  O'Connor Owen A
Affiliation:1. Department of Medicine, Memorial Sloan‐Kettering Cancer Center, , New York, NY, USA;2. Department of Medicine, Weill‐Cornell Medical College, , New York, NY, USA;3. Department of Medicine, UCLA Medical Center, , Los Angeles, CA, USA;4. Department of Pathology, Memorial Sloan‐Kettering Cancer Center, , New York, NY, USA;5. Department of Epidemiology and Biostatistics, Memorial Sloan‐Kettering Cancer Center, , New York, NY, USA;6. Millennium Pharmaceuticals, The Takeda Oncology Company, , Cambridge, MA, USA;7. NYU Langone Medical Center, NYU Cancer Institute, , New York, NY, USA
Abstract:
Keywords:non‐Hodgkin lymphoma  tissue microarray  bortezomib  CFLAR  CDKN1B  MCL1
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号